Results 1 to 10 of about 760,426 (217)
Journal of Patient-Reported Outcomes, 2021 Background In 2019, an estimated 296 million people were living with chronic hepatitis B virus (HBV) globally with approximately 2.4 million living within the United States.
Catherine Freeland +6 more
doaj +1 more source
BMC Gastroenterology, 2022 Introduction In 2016 the World Health Organization (WHO) had adopted a global strategy to eliminate Hepatitis B (HBV) by 2030 through five core interventions.
Zhuo-zhi Lim +3 more
doaj +1 more source
Trends of the Global Hepatitis C Disease Burden: Strategies to Achieve Elimination [PDF]
Journal of Preventive Medicine and Public Health, 2021 Hepatitis C infection is responsible for high morbidity and mortality rates globally as well as for significant indirect costs. The disease burden caused by the hepatitis C virus (HCV) is comparable to the one caused by human immunodeficiency virus or ...
Nathalie Brunner, Philip Bruggmann
doaj +1 more source
Archives of Public Health, 2021 Background Co-infection between hepatitis B virus (HBV) and hepatitis delta virus (HDV) causes the severest chronic hepatitis and is associated with a high risk of cirrhosis and hepatocellular carcinoma (HCC).
Tomoyuki Hayashi +10 more
doaj +1 more source
BMC Public Health, 2021 Background An estimated between 257 and 292 million people live with chronic HBV globally. While much is known about the causes, and epidemiology of HBV, little is understood about the quality of life and impact of HBV on those living with the infection.
Catherine Freeland +8 more
doaj +1 more source
Peer-facilitated treatment access for hepatitis C: the Live Hep C Free project
Harm Reduction Journal, 2022 Background This commentary explores the lessons learned during implementation of a peer-facilitated hepatitis C virus (HCV) testing and treatment access project called the Live Hep C Free (LHCF) project in contributing to micro-elimination efforts.
Julia A. Silano +4 more
doaj +1 more source
BMC Infectious Diseases, 2023 Background and aims Refugees are at higher risk for hepatitis B (HBV) and hepatitis C (HCV), but often face unique healthcare barriers to vaccination, testing, and treatment.
Ankeeta Saseetharran +5 more
doaj +1 more source
Usefulness of automated assays for detecting hepatitis B and C markers in dried blood spot samples
BMC Research Notes, 2019 Objective Dried blood spots (DBSs) can be used as an alternative to serum samples because they are easily collected and can be transported without refrigeration to reference laboratories for diagnosis.
Livia Melo Villar +6 more
doaj +1 more source
Automated quality control for a molecular surveillance system
BMC Bioinformatics, 2018 Background Molecular surveillance and outbreak investigation are important for elimination of hepatitis C virus (HCV) infection in the United States. A web-based system, Global Hepatitis Outbreak and Surveillance Technology (GHOST), has been developed ...
Seth Sims +10 more
doaj +1 more source
The hidden effects of COVID-19 on HIV services in Zanzibar: country report
AIDS Research and Therapy, 2023 The COVID-19 pandemic has had a major effect on HIV-related healthcare services. Zanzibar has experienced several interruptions of HIV services in the areas of testing and counselling, prevention of mother-to-child transmission of HIV, key population ...
Mansour Maulid Mshenga +5 more
doaj +1 more source